| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/06/2006 | US20060074066 Use of an inhibitor of cathepsin-S or -B to treat or prevent chronic obstructive pulmonary disease |
| 04/06/2006 | US20060074065 compounds enhance the activity of beta-lactam antibiotics; use to treat antibiotic resistance bacterial infections like otitis, sinusitis, meningitis etc. especially associated with Enterobacter, Citrobacter, and Serratia; Diphenylmethyl 7-phenylacetamido-3-(trifluorosulfonyloxy)-3-cephem-4-carboxylate |
| 04/06/2006 | US20060074064 Tricyclic 6-alkylidene-penems as beta-lactamase inhibitors |
| 04/06/2006 | US20060074063 Pharmacological agent and method of treatment |
| 04/06/2006 | US20060074062 Substituted porphyrins |
| 04/06/2006 | US20060074061 Formulations of glucocorticoids to treat pathologic ocular angiogenesis |
| 04/06/2006 | US20060074060 Steroid 17 beta -hydroxysteroid dehydrogenase inhibitors substituted with one or more oxime groups, especially aromatase inhibitors used in the treatment of endocrine-dependent tumors, especially breast cancer |
| 04/06/2006 | US20060074059 Isomorphic crystalline habits of 3alpha-hydroxy-21-(1'-imidazolyl)-3beta-methoxymethyl-5alpha-pregnane-20-one |
| 04/06/2006 | US20060074058 Combination of dpp iv inhibitor and a cardiovascular compound |
| 04/06/2006 | US20060074057 Use of chenodeoxycholic acid for reducing adipose tissue |
| 04/06/2006 | US20060074056 Inhibitors of VEGF receptor and HGF receptor signaling |
| 04/06/2006 | US20060074054 Phospho-indoles as HIV inhibitors |
| 04/06/2006 | US20060074053 Ophthalmic solution containing quinolone antimicrobial compound |
| 04/06/2006 | US20060074052 Compositions and methods for treating mammals with modified alginates and modified pectins |
| 04/06/2006 | US20060074051 comprising a stem cell and a plurality of amino acids having an alpha carbon, the amino acids being present at a molar ratio which is characteristic of human breast milk protein, and wherein no more than 10% of the amino acids are in D-form |
| 04/06/2006 | US20060074050 Composition and method for treating hyperproliferative diseases |
| 04/06/2006 | US20060074049 Use of heparinoids for treatment and prevention of dementia |
| 04/06/2006 | US20060074048 Mixed esters of hyaluronic acid with retinoic and butyric acids |
| 04/06/2006 | US20060074047 Method of treating inflammation with inhibitors of sialyl transferases |
| 04/06/2006 | US20060074046 Oral administration of decitabine salt |
| 04/06/2006 | US20060074044 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders |
| 04/06/2006 | US20060074041 Antisense and antigene therapeutics with improved binding properties and methods for their use |
| 04/06/2006 | US20060074039 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 04/06/2006 | US20060074038 Her-2 neu dna vaccine having anti-cancer activity |
| 04/06/2006 | US20060074035 Dinucleotide inhibitors of de novo RNA polymerases for treatment or prevention of viral infections |
| 04/06/2006 | US20060074034 Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof |
| 04/06/2006 | US20060074032 Synthesis and separation of optically active isomers of erythromycin and their biological actions |
| 04/06/2006 | US20060074031 D-pyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 04/06/2006 | US20060074030 For cancer therapy |
| 04/06/2006 | US20060074029 Topical antimicrobial composition having improved moisturization properties |
| 04/06/2006 | US20060074028 Local, regionally-restricted delivery to an axon in situ of an ubiquitin-proteasome system inhibitor, optionally in conjunction with a microtubule stabilizing reagent, and detection the resultant reduction in axon trauma or axotomyn |
| 04/06/2006 | US20060074025 Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability |
| 04/06/2006 | US20060074017 Active complex of alpha-lactalbumin (hamlet) and cofactor |
| 04/06/2006 | US20060074013 Insulin, insulin-related peptide, and sensitizer; side effect reduction |
| 04/06/2006 | US20060074011 pH above 5.5 may be delivered to a subject with reduced pain |
| 04/06/2006 | US20060073578 Process for producing unsaturated fatty acid-containing oils |
| 04/06/2006 | US20060073569 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073518 Method for selecting a candidate drug compound |
| 04/06/2006 | US20060073516 Novel screening method |
| 04/06/2006 | US20060073479 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness |
| 04/06/2006 | US20060073472 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 04/06/2006 | US20060073333 Dispersing a matrix of nanostructured liquid phase or a dehydrated variant and a nanostructured liquid crystalline phase or a dehydrated variant in nonlamellar material; cooling or evaporating a volatile solvent |
| 04/06/2006 | US20060073223 Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent |
| 04/06/2006 | US20060073222 Saponin mixtures and compounds isolated from Acacia victoriae; glycosides of acacic or oleanolic acid; control of cell apoptosis and cytotoxicity; antitumor, -carcinogenic, -inflammatory and -proliferative agents; atherosclerosis |
| 04/06/2006 | US20060073217 Methods of preventing weight gain |
| 04/06/2006 | US20060073216 Compositions and methods for control of bovine mastitis |
| 04/06/2006 | US20060073214 Colon cleansing composition and method |
| 04/06/2006 | US20060073213 Reducing ER stress in the treatment of obesity and diabetes |
| 04/06/2006 | US20060073209 Nanoparticles for targeting hepatoma cells |
| 04/06/2006 | US20060073203 Dry polymer and lipid composition |
| 04/06/2006 | US20060073200 Lercanidipine capsules |
| 04/06/2006 | US20060073198 Sustained release of antifectives |
| 04/06/2006 | US20060073197 Encapsulated transfer factor compositions and methods of use |
| 04/06/2006 | US20060073196 Use of p-glycoprotein inhibitor surfactants at the surface of a colloidal carrier |
| 04/06/2006 | US20060073192 Composition and method for use in cartilage affecting conditions |
| 04/06/2006 | US20060073191 B-1, 4-mannobiose-containing composition |
| 04/06/2006 | US20060073187 Use of arachidonic acid for normalization of infradian rhythm |
| 04/06/2006 | US20060073186 Nutritional compositions |
| 04/06/2006 | US20060073183 Therapeutic composition and a method of coating implantable medical devices |
| 04/06/2006 | US20060073182 Conveniently implantable sustained release drug compositions |
| 04/06/2006 | US20060073178 injecting an injectable composition containing a growth factor and hyaluronic acid as a carrier into the dermis, the hypodermis, or both, in various areas of face, or selected areas of the body of a person to stimulate collagen, elastin, or fat cell production, thereby restoring age related tissue loss |
| 04/06/2006 | US20060073176 Water-soluble composition containing coenzyme q10 |
| 04/06/2006 | US20060073175 Methods and formulations for delivery of pharmacologically active agents |
| 04/06/2006 | US20060073172 Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure |
| 04/06/2006 | US20060073169 Acellular antibordetella vaccine |
| 04/06/2006 | US20060073162 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 04/06/2006 | US20060073156 Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract |
| 04/06/2006 | US20060073151 Inhibitors of extracellular Hsp90 |
| 04/06/2006 | US20060073150 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 04/06/2006 | US20060073140 Dual-specificity antibody having specificity for both an activated erbB2 receptor and erbB1 dimers, without significant affinity for monomeric EGFr that is not activate; specificity of the antibodies is due to their recognition and binding of activation epitopes; diagnosis, imaging and for treating tumor |
| 04/06/2006 | US20060073138 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 04/06/2006 | US20060073131 Coenzyme Q compositions persisting in blood |
| 04/06/2006 | US20060073130 reducing a symptom of psoriasis by administering a composition comprising Bacillus coagulans bacteria in an amount effective to reduce serum TNF- alpha levels; skin disorders |
| 04/06/2006 | US20060073122 Method for activating human antigen presenting cells, activated human antigen - presenting cells, and use thereof |
| 04/06/2006 | US20060073118 Methods of activating NKT cells |
| 04/06/2006 | US20060073114 Compounds and methods to inhibit or augment an inflammatory response |
| 04/06/2006 | US20060073113 Polyalkylene glycol derivative and modified bio-related substance |
| 04/06/2006 | US20060073107 Use of vitamin D3 (cholecalciferol) in sunscreens |
| 04/06/2006 | US20060073104 ApoE4 domain interaction inhibitors and methods of use thereof |
| 04/06/2006 | US20060073103 Controlled Dosage Aerosols With Lecithin As Surface-Active Agent |
| 04/06/2006 | US20060073102 Abuse-resistant opioid solid dosage form |
| 04/06/2006 | US20060073100 Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions |
| 04/06/2006 | US20060073098 Irrigating solution for neurosurgical procedures |
| 04/06/2006 | DE60202958T2 Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten Stable polymorph of flibanserin, industrial process for its production and its use for the preparation of medicaments |
| 04/06/2006 | DE10231370B4 Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Thiophenglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 04/06/2006 | DE102004049015A1 Use of acids to stabilize chloral hydrate, especially in pharmaceutical compositions for filling gelatin capsules |
| 04/06/2006 | DE102004049008A1 Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur New uses for α-agonists with 2-imidazoline |
| 04/06/2006 | DE102004048388A1 D-Pyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung D-pyranosyl-substituted phenyls, medicaments containing these compounds, their use and process for their preparation |
| 04/06/2006 | DE102004047869A1 Verfahren zur enzymatischen Synthese von Pyroglutaminsäureestern A process for the enzymatic synthesis of esters of pyroglutamic acid |
| 04/06/2006 | DE102004047272A1 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase |
| 04/06/2006 | DE102004046142A1 New lydiamycin cyclodepsipeptides useful for controlling diseases cause by mycobacteria, e.g. tuberculosis and leprosy |
| 04/06/2006 | DE102004045220A1 Neue Arzneimittel New drugs |
| 04/06/2006 | DE102004042441A1 Mit Aminosäuren substituierte Hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel With amino acids substituted hexahydro-pyrazino (1,2-a) pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments |
| 04/06/2006 | CA2848573A1 Rnai modulation of apob and uses thereof |
| 04/06/2006 | CA2824308A1 Targeting opposite strand replication intermediates of single-stranded viruses by rnai |
| 04/06/2006 | CA2603290A1 Prazole derivatives and salts thereof and use of same |
| 04/06/2006 | CA2585592A1 Modified coffee, method of roasting coffee bean, coffee-like supplement and auxiliary food |
| 04/06/2006 | CA2583464A1 Ecteinascidin compounds as anti -inflammatory agents |
| 04/06/2006 | CA2583397A1 Therapeutic agents targeting the ncca-atp channel and methods of use thereof |